Lv1
40 积分 2024-08-22 加入
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
3天前
已完结
Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling
7天前
已完结
Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?
10天前
已完结
Weight loss and body composition after compounded semaglutide treatment in a real world setting
16天前
已完结
Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice
29天前
已完结
Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice
1个月前
已完结
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review
1个月前
已完结
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
1个月前
已完结
Targeting the incretin system in obesity and type 2 diabetes mellitus
1个月前
已完结
Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF
1个月前
已完结
皖公网安备34019202002308
